A detailed history of Arcadia Investment Management Corp transactions in Abbott Laboratories stock. As of the latest transaction made, Arcadia Investment Management Corp holds 4,596 shares of ABT stock, worth $528,494. This represents 0.09% of its overall portfolio holdings.

Number of Shares
4,596
Previous 4,598 0.04%
Holding current value
$528,494
Previous $477,000 9.64%
% of portfolio
0.09%
Previous 0.08%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 29, 2024

SELL
$100.07 - $118.13 $200 - $236
-2 Reduced 0.04%
4,596 $523,000
Q2 2024

Aug 05, 2024

SELL
$100.73 - $112.44 $226,642 - $252,990
-2,250 Reduced 32.86%
4,598 $477,000
Q1 2024

Apr 23, 2024

SELL
$109.52 - $120.96 $213,344 - $235,630
-1,948 Reduced 22.15%
6,848 $778,000
Q4 2023

Feb 07, 2024

SELL
$90.19 - $110.4 $45,004 - $55,089
-499 Reduced 5.37%
8,796 $968,000
Q3 2023

Oct 23, 2023

SELL
$95.53 - $114.62 $19,010 - $22,809
-199 Reduced 2.1%
9,295 $900,000
Q2 2023

Jul 24, 2023

SELL
$100.78 - $112.29 $15,117 - $16,843
-150 Reduced 1.56%
9,494 $1.04 Million
Q1 2023

May 05, 2023

SELL
$96.86 - $114.01 $157,688 - $185,608
-1,628 Reduced 14.44%
9,644 $976,000
Q4 2022

Feb 08, 2023

SELL
$95.06 - $111.52 $313,127 - $367,346
-3,294 Reduced 22.61%
11,272 $1.24 Million
Q3 2022

Oct 19, 2022

SELL
$96.76 - $112.03 $87,084 - $100,827
-900 Reduced 5.82%
14,566 $1.41 Million
Q2 2022

Jul 21, 2022

SELL
$102.07 - $123.37 $164,026 - $198,255
-1,607 Reduced 9.41%
15,466 $1.68 Million
Q1 2022

Apr 28, 2022

BUY
$114.02 - $139.04 $102,161 - $124,579
896 Added 5.54%
17,073 $2.02 Million
Q4 2021

Feb 09, 2022

BUY
$115.53 - $141.46 $154,232 - $188,849
1,335 Added 8.99%
16,177 $2.28 Million
Q3 2021

Nov 10, 2021

SELL
$116.66 - $129.06 $2,566 - $2,839
-22 Reduced 0.15%
14,842 $1.75 Million
Q2 2021

Aug 02, 2021

BUY
$105.79 - $124.53 $199,731 - $235,112
1,888 Added 14.55%
14,864 $1.72 Million
Q1 2021

Apr 30, 2021

BUY
$108.84 - $128.23 $10,557 - $12,438
97 Added 0.75%
12,976 $1.56 Million
Q4 2020

Feb 11, 2021

SELL
$105.0 - $114.42 $91,350 - $99,545
-870 Reduced 6.33%
12,879 $1.41 Million
Q2 2020

Aug 11, 2020

BUY
$76.57 - $98.0 $93,032 - $119,070
1,215 Added 9.69%
13,749 $1.26 Million
Q1 2020

May 13, 2020

BUY
$62.82 - $91.86 $92,031 - $134,574
1,465 Added 13.24%
12,534 $989,000
Q4 2019

Jan 29, 2020

BUY
$78.51 - $87.4 $31,404 - $34,960
400 Added 3.75%
11,069 $961,000
Q3 2019

Oct 22, 2019

BUY
$81.84 - $88.74 $47,058 - $51,025
575 Added 5.7%
10,669 $893,000
Q2 2019

Jul 23, 2019

BUY
$72.88 - $85.0 $129,945 - $151,555
1,783 Added 21.45%
10,094 $849,000
Q4 2018

Jan 17, 2019

SELL
$65.56 - $74.27 $46,350 - $52,508
-707 Reduced 7.84%
8,311 $601,000
Q1 2018

Apr 19, 2018

SELL
$56.27 - $63.62 $5,627 - $6,362
-100 Reduced 1.1%
9,018 $540,000
Q3 2017

Oct 18, 2017

BUY
$48.06 - $53.64 $438,211 - $489,089
9,118
9,118 $487,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $201B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Arcadia Investment Management Corp Portfolio

Follow Arcadia Investment Management Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Arcadia Investment Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on Arcadia Investment Management Corp with notifications on news.